EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Radioprotective and radiosensitizing properties of silymarin/silibinin in response to ionizing radiation

Faezeh Arghidash, Fatemeh Gheybi, Hamid Gholamhosseinian, Prashant Kesharwani, Amirhossein Sahebkar

Pathology - Research and Practice · 2025

DOI: 10.1016/j.prp.2025.156002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2025. Verfasst von Faezeh Arghidash und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; Student Research …. Hauptthemen laut MEDLINE: Radiation-Sensitizing Agents, Radiation-Protective Agents, Silymarin, Silybin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 199 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is a health and treatment challenge that the world is facing, and many efforts are being made to develop treatment solutions for all forms of cancer. Radiotherapy (RT), one of the cancer treatment methods, can cause toxicity in healthy cells, even though it has positive effects on killing cancer cells. It is possible for cancer cells to develop resistance to radiotherapy. To address these issues, it can be beneficial to combine treatments. Combining plants with conventional cancer treatment is a viable option, and their potential can be utilized in this area. The therapeutic properties of silymarin and its active ingredient silibinin have been used in traditional medicine for a long time. The purpose of this review is to investigate the radioprotective and radio-sensitizing properties of silymarin/silibinin in cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Radiation-Sensitizing AgentsRadiation-Protective AgentsSilymarinSilybinNeoplasmsHumansAnimalsRadiation, Ionizing

Stichwörter der Autor:innen

CancerRadioprotectiveRadiosensitizerRadiotherapySilibininSilymarin

Substanzen

Radiation-Sensitizing AgentsRadiation-Protective AgentsSilymarinSilybin

Autor:innen und Institutionen

  • Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University…
  • Medical Physics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar, Madhya Pradesh 470003, India; University Institute of Pharma Sciences, Chandigarh University, Mohali, Punjab, India. Electronic address:…
  • Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Centre for Research Impact & Outcome, Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab 140401, India; Biotechn…

Zitieren

APA

Arghidash, F., Gheybi, F., Gholamhosseinian, H., Kesharwani, P., & Sahebkar, A. (2025). Radioprotective and radiosensitizing properties of silymarin/silibinin in response to ionizing radiation. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2025.156002

Vancouver

Arghidash F, Gheybi F, Gholamhosseinian H, Kesharwani P, Sahebkar A. Radioprotective and radiosensitizing properties of silymarin/silibinin in response to ionizing radiation. Pathology - Research and Practice. 2025. doi:10.1016/j.prp.2025.156002

BibTeX
@article{Arghidash2025,
  author = {Arghidash, Faezeh and Gheybi, Fatemeh and Gholamhosseinian, Hamid and Kesharwani, Prashant and Sahebkar, Amirhossein},
  title = {Radioprotective and radiosensitizing properties of silymarin/silibinin in response to ionizing radiation},
  journal = {Pathology - Research and Practice},
  year = {2025},
  doi = {10.1016/j.prp.2025.156002}
}
Kostenlos starten →